font size
printPrint


Business: Drug Development

Subtopics:

DRUG DEVELOPMENT:

Blood Simple

Trellis Bioscience is pursuing several preclinical candidates, but its antibody discovery engine is where its star power lies.


Trellis Bioscience's CellSpot technology may produce images that look like stars from a distant galaxy, but the subjects are quite earthbound. The technology allows the company to rapidly screen large collections of antibodies, including human blood, to find rare ones with the greatest therapeutic potential.

READ MORE.

 

  • Heading East    
    Big Pharma is shelling out big bucks in China's much of it going to world-class research centers.
    January 18, 2008 - K.C. SWANSON - Business - Drug Development
  • Arming the War on Cancer
    Nearly 650 new drugs in development in the oncology pipeline to fuel the fight.
    December 18, 2007 - Business - Drug Development
  • An Ounce of Prevention
    Changing reimbursement rules promise to create demand for product with a once dim future.
    December 10, 2007 - DANIEL S. LEVINE - Business - Drug Development
  • Dead Meat    
    Biotech and pharma companies that don't embrace a new model of business are destined to become irrelevant.
    December 07, 2007 - G. STEVEN BURRILL, DUANE ROTH, and DAVE JOHNSON - Business - Drug Development
  • A Fledgling Drug-making Process    
    Which came first, the chicken or the biopharmaceutical factory?
    December 06, 2007 - SUZANNE ELVIDGE - Business - Drug Development
  • No Silver Bullet    
    Researchers aren't terribly hopeful yet about finding a cure for Alzheimer's, but progress on detection and therapeutics could lead to more effective treatments.
    November 06, 2007 - APRIL LYNCH - Business - Drug Development
  • Targeted Chemotherapy
    Genentech looks to build a drug delivery platform with its monoclonal antibodies, and technology to link them to potent cancer drugs.
    November 05, 2007 - DANIEL S. LEVINE - Business - Drug Development
  • RX For Stroke Victims: Irish Coffee - Iced
    A San Diego company believes a mixture of caffeine and alcohol along with its cooling technology might minimize damage to the brain when the flow of blood becomes blocked.
    October 22, 2007 - DANIEL S. LEVINE - Business - Drug Development
  • Searching for a Better Morphine    
    Better understanding of pain's pathways are leading to promising ways for treating chronic and acute pain.
    October 15, 2007 - LAWRENCE M. FISHER - Business - Drug Development
  • Making Chemo Irresistible
    A virtual biopharma has a late-stage cancer drug with an encouraging safety profile that may be able to turn chemo-resistant cancer cells vulnerable.
    October 05, 2007 - DANIEL S. LEVINE - Business - Drug Development
  • An Injection of Hope    
    A vaccine in tests for one rare form of cancer has patients living more than twice as long as those treated by radiation and chemotherapy.
    October 01, 2007 - BRUCE GOLDMAN - Business - Drug Development
  • Pfizer Alters Its DNA
    As key products come off patent, the drug giant looks to biologics to help build its future.
    August 29, 2007 - DANIEL S. LEVINE - Business - Drug Development
  • Delivering the Goods
    $1 billion RNAi deal heats up sector, but hurdles for the technology remain.
    July 12, 2007 - DANIEL S. LEVINE - Business - Drug Development
  • Expiring Revenue
    Leading pharmaceutical companies face substantial hits to the top line with patents set to expire.
    June 18, 2007 - Business - Drug Development
  • Innovation Gap Widens
    June 11, 2007 - Business - Drug Development
  • Eye on the Street
    The latest news and numbers from Wall Street.
    January 22, 2008 - Business - Markets
  • Eye on the Street
    The latest news and numbers from Wall Street.
    January 22, 2008 - Business - Markets
  • The Ant and the Grasshopper    
    Insect-derived drugs are the next big thing. But finding them means a race against time.
    September 01, 2007 - By Robert R. Dunn - Science - Research
  • A Digital Liver
    Federal regulators hope computer modeling can identify drugs that damage the liver before they do harm.
    August 13, 2007 - DANIEL S. LEVINE - Science - Technology
  • Hatching Companies
    Pfizer gets first tenant for its incubator as it hopes to tap new ideas from outside to help fill the evolving void from drugs going off patent.
    July 20, 2007 - DANIEL S. LEVINE - Health - Drug Delivery
  • True Romance
    Genentech shows it can attract a big pharma partner to take role traditionally played by smaller biotechs.
    June 27, 2007 - DANIEL S. LEVINE - Business - Dealmaking
  • In A Pig's Islet
    Australian company ready to enter clinic with encapsulated pig cells.
    May 14, 2007 - DANIEL S. LEVINE - Health - Regenerative Medicine